ESOPMay 1, 2026, 04:58 PM
NewAmsterdam Pharma Grants 50,400 Options, 15,400 RSUs to New Hires
AI Summary
NewAmsterdam Pharma announced that its Compensation Committee approved the grant of inducement equity awards to five non-executive new hires. The awards include 50,400 share options with an exercise price of $28.43, vesting over four years, and 15,400 restricted stock units (RSUs), vesting over three years. These grants were made under the 2024 Inducement Plan to attract new talent.
Key Highlights
- NewAmsterdam Pharma granted 50,400 inducement share options to five non-executive new hires.
- Share options have an exercise price of $28.43, based on the May 1, 2026 closing price.
- Share options vest over four years: 25% on the first anniversary, then monthly over 36 months.
- The company also granted 15,400 restricted stock units (RSUs) to the same five new hires.
- RSUs vest over three years, with one-third vesting on each of the one, two, and three-year anniversaries.
- Both grants were made under the 2024 Inducement Plan and Nasdaq Listing Rule 5635(c)(4).
Price Impact
More from NAMS